Bank Of New York Mellon Corp Idera Pharmaceuticals, Inc. Transaction History

Bank Of New York Mellon Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.23 - $0.43 $3,377 - $6,314	14,685 New	14,685 $5,000
Q1 2021 May 13, 2021	SELL	$1.23 - $5.98 $2,597 - $12,629	-2,112 Reduced 12.57%	14,685 $19,000
Q2 2020 Aug 12, 2020	SELL	$1.23 - $2.12 $1 - $2	-1 Reduced 0.01%	16,797 $30,000
Q1 2020 May 06, 2020	BUY	$1.06 - $2.15 $1 - $2	1 Added 0.01%	16,798 $22,000
Q4 2019 Feb 14, 2020	SELL	$1.45 - $2.79 $62,658 - $120,564	-43,213 Reduced 72.01%	16,797 $30,000

Q3 2019 Nov 07, 2019	BUY	$2.12 - $3.31 $33,074 - $51,639	15,601 Added 35.13%	60,010 $173,000
Q2 2019 Aug 12, 2019	SELL	$2.37 - $3.97 $30,324 - $50,796	-12,795 Reduced 22.37%	44,409 $119,000
Q1 2019 May 14, 2019	SELL	$2.33 - $3.79 $1,165 - $1,895	-500 Reduced 0.87%	57,204 $145,000
Q4 2018 Feb 11, 2019	SELL	$2.77 - $9.38 $2,362 - $8,001	-853 Reduced 1.46%	57,704 $160,000
Q3 2018 Nov 09, 2018	BUY	$5.53 - $11.36 $323,820 - $665,207	58,557 New	58,557 $0

Ticker IDRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,296,900
Market Cap $188M
Description
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.